Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 7, 2005, Pages 920-923

  Groisman, Gabriel M ^a   Bernheim, Joelle ^b   Halpern, Marisa ^c   Brazowsky, Eli ^d   Meir, Alona ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c HASHARON HOSPITAL   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BREAST CARCINOMA; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOSCOPIC BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE EPITHELIUM; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCINOUS CARCINOMA; OVARY ADENOCARCINOMA; PANCREAS CARCINOMA; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; BREAST TUMOR; COLORECTAL TUMOR; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; OVARY TUMOR; PANCREAS TUMOR; PATHOLOGY; PROSTATE TUMOR; STOMACH TUMOR;

CDX2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 21344453737     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Geboes K. Rare and secondary (metastatic) tumors of the large intestine. In: Whitehead R, ed. Gastrointestinal and Oesophageal Pathology. 2nd ed. Edinburgh: Churchill Livingstone; 1995:910-924.
2. Libshitz HI, Lindell MM, Dodd CD. Metastases to the hollow viscera. Radiol Clin North Am. 1982;20:487-499.
3. Caramella E, Bruneton J-N, Roux P, et al. Metastases of the digestive tract: report of 77 cases and review of the literature. Eur J Radiol. 1983;3:331-338.
4. Feczko PJ, Collins DD, Mezwa DG. Metastatic disease involving the gastrointestinal tract. Radiol Clin North Am. 1993;31:1359-1373.
5. Barbareschi M, Murer B, Colby TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal metastases to the lungs. Am J Surg Pathol. 2003; 27:141-149.
6. Moskaluk CA, Zhang H, Powell SM, et al. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913-919.
7. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310.
8. Li MK, Folpe AL. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol. 2004;11:101-105.
9. Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004;17:1392-1399.
10. Berge T, Lundberg S. Cancer in Malmo 1958-1969: an autopsy study. Acta Pathol Microbiol Scand Suppl. 1977;260:140-149.
11. Winston CB, Hadar O, Teitcher, et al. Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. Am J Roentgenol. 2000;175:795-800.
12. Taal BC, den Hartog Jager FC, Steinmetz R, Peterse H. The spectrum of gastrointestinal metastases of breast carcinoma, II: the colon and rectum. Gastrointest Endosc. 1992;38:136-141.
13. Sastre-Carau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P. Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-120.
14. Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol. 1995;9: 426-429.
15. Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol. 1998;29:491-497.
16. Kende AI, Carr NJ, Sobin LH. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology. 2003;42:137-140.
17. Suh E, Chen L, Taylor J, Traber PG. A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol. 1994;14: 7340-7351.
18. Suh E, Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol. 1996;16:619-625.
19. Silberg DJ, Swain GP, Suth ER, Traber PG. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology. 2000;119:961-971.
20. Bai Y-Q, Yamamoto H, Akiyama Y, et al. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett. 2002;176:47-55.
21. Almeida R, Silva E, Santos-Silva F, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol. 2003;199:36-40.
22. Phillips RW, Frierson HF, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003;27:1442-1447.
23. Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol. 2004;17:1282-1288.
24. Groisman GM, Meir A, Sabo E. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Int J Gynecol Pathol. 2004;23:52-57.
25. Fraggetta F, Pelosi G, Cafici A, Scollo P, Nuciforo P, Viale G. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. Virchows Arch. 2003;443:782-786.
26. Adsay NV, Merati K, Basturk O. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839-848.
27. Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol. 2001;159:2239-2248.